These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 18926667
1. High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal. Fernandes R, Gestoso A, Freitas JM, Santos P, Prudêncio C. Int J Antimicrob Agents; 2009 Feb; 33(2):184-5. PubMed ID: 18926667 [No Abstract] [Full Text] [Related]
2. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D. Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295 [Abstract] [Full Text] [Related]
3. Emergence of extended-spectrum beta-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates. Mac Aogáin M, Mooij MJ, Adams C, Clair J, O'Gara F. Diagn Microbiol Infect Dis; 2010 May; 67(1):106-9. PubMed ID: 20385353 [Abstract] [Full Text] [Related]
4. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Kumar MS, Lakshmi V, Rajagopalan R. Indian J Med Microbiol; 2006 Jul; 24(3):208-11. PubMed ID: 16912442 [Abstract] [Full Text] [Related]
5. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. Potz NA, Hope R, Warner M, Johnson AP, Livermore DM, London & South East ESBL Project Group. J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428 [Abstract] [Full Text] [Related]
6. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases. Sanders CC. J Chemother; 1996 Feb; 8 Suppl 2():57-62. PubMed ID: 8738847 [Abstract] [Full Text] [Related]
7. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001. Boutiba-Ben Boubaker I, Ghozzi R, Ben Abdallah H, Mamlouk K, Kamoun A, Ben Redjeb S. Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883 [Abstract] [Full Text] [Related]
8. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study. Silva-Sanchez J, Reyna-Flores F, Velazquez-Meza ME, Rojas-Moreno T, Benitez-Diaz A, Sanchez-Perez A, Study Group. Diagn Microbiol Infect Dis; 2011 Jun; 70(2):270-3. PubMed ID: 21596226 [Abstract] [Full Text] [Related]
10. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Drieux L, Brossier F, Sougakoff W, Jarlier V. Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532 [Abstract] [Full Text] [Related]
11. Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, de Mendonça R, Jans B, Glupczynski Y. J Antimicrob Chemother; 2011 Jan; 66(1):37-47. PubMed ID: 21036771 [Abstract] [Full Text] [Related]
12. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. Spanu T, Sanguinetti M, Tumbarello M, D'Inzeo T, Fiori B, Posteraro B, Santangelo R, Cauda R, Fadda G. J Clin Microbiol; 2006 Sep; 44(9):3257-62. PubMed ID: 16954257 [Abstract] [Full Text] [Related]
13. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents. Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS. Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175 [Abstract] [Full Text] [Related]
14. beta-Lactams without a suicide inhibitor. Giamarellou H. Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547 [Abstract] [Full Text] [Related]
15. Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands. al Naiemi N, Bart A, de Jong MD, Vandenbroucke-Grauls CM, Rietra PJ, Debets-Ossenkopp YJ, Wever PC, Spanjaard L, Bos AJ, Duim B. J Clin Microbiol; 2006 Aug; 44(8):3012-4. PubMed ID: 16891530 [Abstract] [Full Text] [Related]
16. Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England. Hope R, Warner M, Potz NA, Fagan EJ, James D, Livermore DM. J Antimicrob Chemother; 2006 Dec; 58(6):1312-4. PubMed ID: 17035342 [No Abstract] [Full Text] [Related]
18. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints. Kahlmeter G. Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542 [Abstract] [Full Text] [Related]
19. Extended-spectrum beta-lactamases: a call for improved detection and control. Paterson DL, Yu VL. Clin Infect Dis; 1999 Dec; 29(6):1419-22. PubMed ID: 10585789 [No Abstract] [Full Text] [Related]
20. Emergence of metallo-β-lactamases in Enterobacteriaceae from Argentina. Gomez S, Rapoport M, Togneri A, Viegas-Caetano J, Faccone D, Corso A, Petroni A, Pasteran F. Diagn Microbiol Infect Dis; 2011 Jan; 69(1):94-7. PubMed ID: 21146720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]